Antiplatyhelmintic agent

Antiplatyhelmintic agents are a class of pharmaceutical drugs used in the treatment of platyhelminth infections. Platyhelminths, also known as flatworms, include a variety of parasitic worms that can cause significant health problems in humans and animals.

Overview

Antiplatyhelmintic agents work by targeting the unique biological characteristics of platyhelminths, disrupting their life cycle and ultimately leading to their death. These agents are used in the treatment of a variety of infections, including schistosomiasis, tapeworm infections, and fluke infections.

Mechanism of Action

The mechanism of action of antiplatyhelmintic agents varies depending on the specific drug. Some agents, such as praziquantel, work by increasing the permeability of the platyhelminth's cell membrane to calcium ions, causing paralysis and death of the worm. Other agents, such as triclabendazole, inhibit the worm's tubulin polymerization, disrupting its ability to maintain its structure and function.

Common Antiplatyhelmintic Agents

Several antiplatyhelmintic agents are commonly used in clinical practice. These include:

• Praziquantel: This is the drug of choice for treating schistosomiasis and many other platyhelminth infections. It is effective against both adult and immature worms.
• Triclabendazole: This drug is primarily used for the treatment of liver fluke infections.
• Niclosamide: This is used for the treatment of tapeworm infections.

Side Effects

Like all drugs, antiplatyhelmintic agents can cause side effects. These can include gastrointestinal symptoms such as nausea and diarrhea, as well as more serious effects such as liver damage and allergic reactions. It is important for patients to discuss potential side effects with their healthcare provider before starting treatment.

See Also

• Anthelmintic
• Parasitic worm
• Schistosomiasis
• Tapeworm
• Fluke

References

This article is a stub related to pharmacology. You can help WikiMD by expanding it!